A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation

NCT01572727 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

416

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Paclitaxel
DRUG: BKM120 matching placebo
DRUG: BKM120

Sponsor

Novartis Pharmaceuticals